The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of high sensitive IHC, FISH, and RT-PCR direct sequencing for detection of ALK translocation in lung cancer.
T. Mitsudomi
Consultant or Advisory Role - Pfizer
Honoraria - Chugai Pharma
K. Tomizawa
No relevant relationships to disclose
Y. Horio
No relevant relationships to disclose
T. Hida
No relevant relationships to disclose
Y. Yatabe
No relevant relationships to disclose